Institution: Global Studies Institute, University of Geneva; Dept of Business Studies, Uppsala
Role with AMR - One Health Consortium: Collaborator
Dr. Chantal Morel’s work focusses on economic issues related to infectious diseases. Most of her work over the past 12 years has been on issues related to antimicrobial resistance – including resistance surveillance, antibiotic stewardship, R&D incentives, system-wide sustainable use measures, access to newer antibiotics, post-market drug performance measures, and supply chain issues. Her most recent project explores the granting of staged bonuses to companies who produce antibiotics that remain effective over time.
Key Areas of Expertise: Economics, Health economics, Incentives, Bonus, Research and Development